Libertyville, IL, United States of America

David A Betebenner

This inventor holds 38 USPTO granted patents and 5 published patent applications, plus 9 CIPO patents and 19 EPO patents, primarily in Anti-Viral Compounds. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Abbott Products Gmbh. Active years: 1992-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Betebenner. Retrieved from https://idiyas.com/inventor/david-a-betebenner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 5)

% Patents Active = 86.8

CIPO Patents = 9 (Patent Applications = 10)

EPO Patents = 19 (Patent Applications = 23)

Average Co-Inventor Count = 13.1

ph-index = 8

Forward Citations = 384(Granted Patents)

Location History:

Vernon Hills, IL (US) (1992 - 1994)
Gurnee, IL (US) (1999 - 2011)
Lawrenceville, NJ (US) (2001 - 2013)
Libertyville, IL (US) (2008 - 2017)
Grayslake, IL (US) (2014 - 2018)

Company Filing History:

19 out of 4,188

Abbott Laboratories Corporation

Bristol-Myers Squibb Compnay

patents

where one patent can have more than one assignee

Years Active: 1992-2018

Loading Chart...

Areas of Expertise:

Anti-Viral Compounds

Hepatitis C Inhibitors

Anti-Infective Agents

Retroviral Protease Inhibitors

Cyclopropyl-Fused Pyrrolidine

Dipeptidyl Peptidase IV

Fluorescence Polarization Immunoassay

Matrix Metalloproteinase Inhibitors

Antiviral Compounds

Inhibitors

Compounds

Uses

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10039754 - Anti-viral compounds (2018-08-07),

2. 10028937 - Anti-viral compounds (2018-07-24),

3. 9637478 - Antiviral compounds and uses thereof (2017-05-02),

4. 9586978 - Anti-viral compounds (2017-03-07),

5. 9567355 - Hepatitis C inhibitors and uses thereof (2017-02-14),

6. 9453007 - Hepatitis C inhibitors and uses thereof (2016-09-27),

7. 9353091 - Antiviral compounds and uses thereof (2016-05-31),

8. 9173887 - Hepatitis C inhibitors and uses thereof (2015-11-03),

9. 9139536 - Anti-infective agents and uses thereof (2015-09-22),

10. 9006387 - Anti-viral compounds (2015-04-14),

11. 8986740 - Anti-infective agents and uses thereof (2015-03-24),

12. 8937150 - Anti-viral compounds (2015-01-20),

13. 8921514 - Anti-viral compounds (2014-12-30),

14. 8748443 - Antiviral compounds and uses thereof (2014-06-10),

15. 8741914 - Antiviral compounds and uses thereof (2014-06-03),

Title: Unveiling the Inventive Journey of David A. Betebenner

Introduction:

David A. Betebenner is a prolific inventor hailing from Libertyville, Illinois, whose innovative spirit has led to the creation of a remarkable 38 patents.

Latest Patents:

Among his latest patents, David has introduced groundbreaking anti-viral compounds that effectively inhibit the replication of the Hepatitis C virus (HCV). These compounds not only showcase his ingenuity but also present novel methods for treating HCV infection.

Career Highlights:

With a career marked by innovation, David has lent his expertise to renowned companies such as Abbott Laboratories Corporation and Abbvie Inc., where his inventive prowess has flourished. His contributions have significantly impacted the field of antiviral research.

Collaborations:

Throughout his journey, David has collaborated with esteemed coworkers, including Todd Warren Rockway and Dachun Liu, fostering a culture of innovation and collective creativity in the workplace.

Conclusion:

In conclusion, David A. Betebenner's inventive journey stands as a testament to his dedication to advancing antiviral research. His numerous patents and collaborations underscore his significant contributions to the scientific community, making him a beacon of innovation in the field.

Profile summary based on public USPTO records.